TCR-Redirected T Cell Treatment in Patients With Recurrent HBV-related Hepatocellular Carcinoma Post Liver Transplantation

NCT04677088 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

7

Enrollment

OTHER

Sponsor class

Conditions

Recurrent Hepatocellular Carcinoma

Interventions

BIOLOGICAL: TCR-T cells

Sponsor

Xiaoshun He

Collaborators

[object Object]